Pharmaceutical regulatory affairs CTD course
Master technical documentation for ICH and FDA compliance. Learn essential guidelines and best practices for regulatory submissions.
Course Content
Pharmaceutical regulatory affairs CTD course is an all-levels Udemy course taught by Moshira Abbas Elmazahy. It runs 1h 28m, is taught in English, and includes a certificate of completion. Learners rate it 5.0 out of 5 from 1 review, with 2 students enrolled. It is a paid course, last updated October 2025.
Understanding the Common Technical Document (CTD): A Comprehensive Guide
The Common Technical Document (CTD) is the globally accepted format for submitting regulatory dossiers to health authorities. This guide provides a detailed overview of the CTD, its structure, and key components.
Section 1: Introduction to the CTD
- What is the CTD? Learn the definition and purpose of the CTD in pharmaceutical submissions.
- CTD History & ICH Guidance: Explore the evolution of the CTD and its foundation in ICH (International Council for Harmonisation) guidelines.
- Benefits of the CTD: Discover how the CTD streamlines regulatory submissions, promoting efficiency and global acceptance.
- CTD Format Principles: Understand the general principles governing the CTD structure.
- CTD Structure: A breakdown of the basic CTD structure, encompassing Modules 1 through 5.
- Module Naming: Learn the purpose and content of each of the five CTD modules.
- The CTD Triangle: A visual representation of the CTD's interconnected components.
- Workshop: Interactive session to solidify CTD understanding.
Section 2: Module III: Quality – Drug Product (CMC)
This section delves into the critical quality aspects of the drug product, focusing on CMC (Chemistry, Manufacturing, and Controls).
- Module III Overview: Comprehensive description and composition of Module III.
- Pharmaceutical Development: Understanding the development process of the drug product.
- Formulation Development: Key considerations in formulating the drug product.
- Manufacturing Process Development: Detailed exploration of the drug product manufacturing process.
- Compatibility: Ensuring compatibility of drug substance and excipients.
- Critical Steps: Identifying and controlling critical steps in manufacturing.
- Manufacturing Process Flow Chart: Visual representation of the manufacturing process.
- Process Control: Implementing effective process control measures.
- Process Validation: Ensuring the manufacturing process consistently produces a quality product.
- Manufacture & Control of Excipients: Managing excipient quality and control.
- Specification Development: Defining specifications for the drug product.
- Analytical Method Validation: Validating methods used to analyze the drug product.
- Justification of Specifications: Rationale behind established specifications.
- Novel Excipients: Addressing the unique considerations for novel excipients.
- Control of Drug Product: Comprehensive control measures for the finished drug product.
- Specification: Detailed specifications for the drug product.
- Analytical Method: Validated analytical methods for drug product testing.
- Validation of Analytical Method: Ensuring the accuracy and reliability of analytical methods.
- Justification of Specification: Scientific rationale for established drug product specifications.
- Characterization of Impurities: Identifying and characterizing impurities in the drug product.
- Batch Analysis: Analysis performed on individual drug product batches.
- Workshop: Hands-on exercises to apply Module III concepts.
Section 3: Module III - Quality (Drug Product) - Further Details
- Reference Standards, SDS, COA: Understanding the role of reference standards, Safety Data Sheets (SDS), and Certificates of Analysis (COA).
- Container Closure System: Details on primary and secondary packaging materials.
- Stability Study: Designing and conducting stability studies to determine shelf life.
- Appendices & Regional Information: Specific requirements and regional variations, including information from Uganda and the GCC (Gulf Cooperation Council).
- Alcohol Content: Regulatory considerations for alcohol content in drug products.
- Excipients from Animal or Human Origin: Specific control measures for excipients derived from animal or human sources.
- Coloring Agents and Diluents: Regulatory considerations for coloring agents and diluents.
- Master Production Documents vs. Batch Manufacturing Records: Understanding the difference between these crucial documents.
- Workshop: Practical application of Module III concepts.
Section 4: Module II: Quality – Drug Substance
This section focuses on the quality aspects of the drug substance (active pharmaceutical ingredient - API).
- DMF (Drug Master File): Detailed information about the DMF of the active substance and its contents, as required by the CTD format.
- COS (Certificate of Suitability) & LOA (Letter of Analysis): Understanding the role of COS and LOA.
- General Information of API: Basic information about the API.
- Manufacture: API manufacturing process details.
- Characterization: API character
Need a SaaS MVP shipped fast? Hire the TutorialSearch.io team
Auth, billing, dashboards and AI features — a launch-ready product built by the devs behind this site.